Johan Hartman
Karolinska Institutet
H-index: 41
Europe-Sweden
Top articles of Johan Hartman
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Prelude to Malignancy: A Gene Expression Signature in Normal Mammary Gland from Breast Cancer Patients Suggests Pre-tumorous Alterations and Is Associated with Adverse Outcomes | bioRxiv | Maria Andreou Marcin Jakalski Katarzyna Duzowska Natalia Filipowicz Anna Kostecka | 2024 |
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer | Breast Cancer Research | Caroline Rönnlund Emmanouil G Sifakis Caroline Schagerholm Qiao Yang Emelie Karlsson | 2024/2/7 |
A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells | Journal of Experimental & Clinical Cancer Research | Pedro Fonseca Weiyingqi Cui Nona Struyf Le Tong Ayushi Chaurasiya | 2024/4/9 |
Abstract PO5-13-02: BRCA mutational profiles of endocrine-resistant breast cancer | Cancer Research | Emelie Karlsson Caroline Schagerholm Stephanie Robertson Hosein Toosi Emmanouil Sifakis | 2024/5/2 |
Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case–control study | British Journal of Surgery | Gunilla Rask Charlotta Wadsten Balazs Acs Johan Hartman Irma Fredriksson | 2024/2 |
Clinical evaluation of deep learning-based risk profiling in breast cancer histopathology and comparison to an established multigene assay | Stephanie Robertson Yinxi Wang Wenwen Sun Emelie Karlsson Sandy Kang Lövgren | 2023/12/1 | |
Abstract PO4-07-05: Clinical evaluation of image-based risk profiling in breast cancer histopathology and comparison to an established gene expression assay | Cancer Research | Stephanie Robertson Yinxi Wang Wenwen Sun Emelie Karlsson Sandy Kang Lövgren | 2024/5/2 |
Development and prognostic validation of a three-level NHG-like deep learning-based model for histological grading of breast cancer | Breast Cancer Research | Abhinav Sharma Philippe Weitz Yinxi Wang Bojing Liu Johan Vallon-Christersson | 2024/1/29 |
Generative AI for virtual HE-staining of whole slide images of unstained breast cancer tissue | Cancer Research | Leena Latonen Umair Khan Sonja Koivukoski Johan Hartman Pekka Ruusuvuori | 2024/3/22 |
Abstract PO4-01-05: The prognostic importance of biological pathway enrichment patterns in trastuzumab-treated early HER2-positive breast cancer | Cancer Research | Caroline Rönnlund Qiao Yang Caroline Schagerholm Theodoros Foukakis Irma Fredriksson | 2024/5/2 |
Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer | Chowdhury Arif Jahangir David B Page Glenn Broeckx Claudia A Gonzalez Caoimbhe Burke | 2024/1/17 | |
Adherence to and optimization of guidelines for Risk of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter study | Una Kjällquist Nikolaos Tsiknakis Balazs Acs Sara Margolin Luisa Edman Kessler | 2024/3/19 | |
Human Epidermal Growth Factor Receptor 2 (HER2) PET Imaging of HER2-Low Breast Cancer with [68Ga] Ga-ABY-025: Results from a Pilot Study | Journal of Nuclear Medicine | Renske Altena Siri af Burén August Blomgren Emelie Karlsson Antonios Tzortzakakis | 2024/5/1 |
Resolving the haplotype complexity of colorectal cancer genomes with droplet barcode sequencing | Humam Siga Pontus Höjer Parham Pourbozorgi Hooman Aghelpasand Max Käller | 2024 | |
Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2-negative breast cancer treated as triple-negative breast cancer: a Swedish population … | The Lancet Regional Health–Europe | Balazs Acs Johan Hartman Demet Sönmez Henrik Lindman Anna LV Johansson | 2024/3/19 |
CopyVAE: a variational autoencoder-based approach for copy number variation inference using single-cell transcriptomics | Bioinformatics | Semih Kurt Mandi Chen Hosein Toosi Xinsong Chen Camilla Engblom | 2024/4/27 |
Abstract PO3-16-04: Distribution of intrinsic subtypes in endocrine-resistant and endocrine-sensitive breast cancer | Cancer Research | Caroline Schagerholm Stephanie Robertson Emelie Karlsson Emmanouil Sifakis Johan Hartman | 2024/5/2 |
Survival outcomes, digital TILs, and on-treatment PET/CT during neoadjuvant therapy for HER2-positive breast cancer: results from the randomized PREDIX HER2 trial | Clinical Cancer Research | Alexios Matikas Hemming Johansson Per Grybäck Judith Bjöhle Balazs Acs | 2023/2/1 |
241MO Patient characteristics and real-world outcomes in HER2 negative/ER zero and ER low patients treated as triple-negative breast cancer in Sweden 2008-2020 | Annals of Oncology | I Fredriksson B Acs J Hartman D Sönmez H Lindman | 2023/10/1 |
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast … | David B Page Glenn Broeckx Chowdhury Arif Jahangir Sara Verbandt Rajarsi R Gupta | 2023/8 |